Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Silence for 34 days

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Oct 13, 2021 3:26pm

165 Views

Post# 34002438

RE:RE:RE:RE:RE:Silence for 34 days

Ya - as per my calculations Doccole ... we need to wait right now.
We couldn't possibly get the details I'm hoping to see if an update came any earlier.
IMO.

Cheers !

Inthepez wrote: Guaranteed all is good science wise. The beef is time frame ie the management side.

Daily SP is meaningless right now. Unless you’re a shorter or lost your allowance like ratbar lmao.

Doccole wrote: I've been waiting for a 730 release. Has anyone had any correspondence with management?

full disclosure-
I have 1 bottle of champagne ready if news is great.
I have 1 glass of chocolate milk ready if news is decent.
I have 1/2 a shot left of cyanide left to finish me if news is bad.